dalteparin has been researched along with Diabetes Mellitus, Gestational in 1 studies
Dalteparin: A low-molecular-weight fragment of heparin, prepared by nitrous acid depolymerization of porcine mucosal heparin. The mean molecular weight is 4000-6000 daltons. It is used therapeutically as an antithrombotic agent. (From Merck Index, 11th ed)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Shi, Y | 1 |
| Qian, J | 1 |
| Zhang, F | 1 |
| Jia, B | 1 |
| Liu, X | 1 |
| Hu, Y | 1 |
| Zhang, Q | 1 |
| Yang, Y | 1 |
| Sun, D | 1 |
| Jiang, L | 1 |
1 other study available for dalteparin and Diabetes Mellitus, Gestational
| Article | Year |
|---|---|
Low molecular weight heparin (nadroparin) improves placental permeability in rats with gestational diabetes mellitus via reduction of tight junction factors.
Topics: Animals; Diabetes, Gestational; Disease Models, Animal; Female; Glycation End Products, Advanced; Na | 2020 |